
Lab Manager recently featured Inorganic Ventures in the article, "Trace-Level Testing, Validation Pressure, and the New Demands on Pharma Labs," examining how pharmaceutical labs are adapting to tighter impurity thresholds
We use cookies to improve functionality and personalize your content. To ensure compliance with the latest e-Privacy directive, we kindly ask for your consent to set these cookies. Learn more.












What does it mean for you?
Understand how CRMs support accurate testing across mining, environmental, pharmaceutical, and industrial applications.


Lab Manager recently featured Inorganic Ventures in the article, "Trace-Level Testing, Validation Pressure, and the New Demands on Pharma Labs," examining how pharmaceutical labs are adapting to tighter impurity thresholds
As part of a planned leadership change at IV Labs of Christiansburg, Virginia, Brian Alexander, Ph.D., has been named president of its subsidiary, Inorganic Ventures. The specialty chemical company is a leading manufacturer of certified reference materials (CRM) and analytical inorganic standards trusted by laboratories worldwide.
He succeeds Christopher Gaines, who served as president of Inorganic Ventures and CEO of IV Labs. Gaines moves to board chair, and Justin Yalung has been named CEO of IV Labs.
Alexander, a geochemist, has served as the company's chief technical officer since 2020 and previously as vice president of technical operations. He brings more than a decade of deep scientific leadership to his new role. His promotion reflects Inorganic Ventures' commitment to science-driven growth and its ambition to strengthen its position as the partner of choice for analytical laboratories and manufacturers across the globe.
“Brian’s journey at Inorganic Ven